Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial

PURPOSE: Cytology and cystoscopy, the current gold standard for diagnosing urothelial carcinomas, have limits: cytology has high interobserver variability with moderate or not optimal sensitivity (particularly for low-grade tumors); while cystoscopy is expensive, invasive, and operator dependent. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebret, Thierry, Paoletti, Xavier, Pignot, Geraldine, Roumiguié, Mathieu, Colombel, Marc, Savareux, Laurent, Verhoest, Grégory, Guy, Laurent, Rigaud, Jérome, De Vergie, Stéphane, Poinas, Grégoire, Droupy, Stéphane, Kleinclauss, François, Courtade-Saïdi, Monique, Piaton, Eric, Radulescu, Camelia, Rioux-Leclercq, Nathalie, Kandel-Aznar, Christine, Renaudin, Karine, Cochand-Priollet, Béatrix, Allory, Yves, Nivet, Sébastien, Rouprêt, Morgan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465399/
https://www.ncbi.nlm.nih.gov/pubmed/37480491
http://dx.doi.org/10.1007/s00345-023-04519-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465399/
https://www.ncbi.nlm.nih.gov/pubmed/37480491
http://dx.doi.org/10.1007/s00345-023-04519-4

Ejemplares similares